Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.24 -0.14 (-0.65%)
As of: Nov 16, 2026 · 9:54 AM EST

Amneal Pharmaceuticals (AMRX) Enterprise Value (2018 - 2026)

Updated

Amneal Pharmaceuticals' Enterprise Value was $6.97 billion in Q3 2026, up 131.3% from $3.01 billion a year earlier and up 27.1% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Enterprise Value (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amneal Pharmaceuticals' Enterprise Value was $6.36 billion through Sep 30, 2026, up 129.5% year-over-year; for FY2025, it was $3.76 billion, up 56.0% from FY2024.

  • Enterprise Value has now increased for three consecutive years, with a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
  • In earlier years, Enterprise Value was $2.41 billion in FY2024 (+33.1%), $1.81 billion in FY2023 (+200.1%), $603.17 million in FY2022 (-50.3%) and $1.21 billion in FY2021 (+16.6%).
  • The Q3 2026 figure marks the highest quarterly Enterprise Value in data going back to Q2 2018.
  • Compared with a year earlier, Enterprise Value has increased for 13 straight quarters, with growth averaging 58.7% over the last eight quarters.
  • The best year-over-year quarter for Enterprise Value over five years was Q1 2024 (growth of 508.6%); the worst was Q1 2023 (a decline of 71.2%).
  • Per Business Quant data, AMRX's Enterprise Value in the three quarters before Q3 2026 was $5.48 billion (Q2 2026), $3.85 billion (Q1 2026) and $3.76 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,304.70 Bn 1,278.32 Bn 20.46 Bn
2 Johnson & Johnson 690.68 Bn 610.54 Bn 17.30 Bn
3 AbbVie 528.28 Bn 496.29 Bn 13.12 Bn
4 Merck 365.24 Bn 328.18 Bn 13.19 Bn
5 Novartis Ag 314.66 Bn 287.90 Bn -
6 Astrazeneca 288.53 Bn 262.05 Bn 13.26 Bn
7 Amgen 253.39 Bn 205.04 Bn 7.58 Bn
8 Gilead Sciences 210.48 Bn 185.59 Bn 6.73 Bn
9 Pfizer 165.27 Bn 112.63 Bn 12.56 Bn
10 Amneal Pharmaceuticals 7.17 Bn 6.41 Bn 334.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.97 Bn
Jun 30, 2026 5.48 Bn
Mar 31, 2026 3.85 Bn
Dec 31, 2025 3.76 Bn
Sep 30, 2025 3.01 Bn
Jun 30, 2025 2.54 Bn
Mar 31, 2025 2.64 Bn
Dec 31, 2024 2.41 Bn
Sep 30, 2024 2.56 Bn
Jun 30, 2024 1.98 Bn
Mar 31, 2024 1.87 Bn
Dec 31, 2023 1.81 Bn
Sep 30, 2023 1.24 Bn
Jun 30, 2023 872.39 Mn
Mar 31, 2023 307.41 Mn
Dec 31, 2022 603.17 Mn
Sep 30, 2022 548.20 Mn
Jun 30, 2022 890.44 Mn
Mar 31, 2022 1.07 Bn
Dec 31, 2021 1.21 Bn
API Access

Amneal Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=AMRX&period=max&api_key=YOUR_API_KEY